Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia

NCT05988710 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT05988710
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05988710 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia
Lead sponsor
Vanderbilt University Medical Center
Phase
Phase 4
Overall status
Recruiting
Start date
October 19, 2023
Completion date
February 29, 2028
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abuse opioids, analgesia, pain